Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$12M Buy
138,804
+390
+0.3% +$34.8K 1.28% 15
2022
Q2
$12.6M Sell
138,414
-343
-0.2% -$30.4K 1.35% 12
2022
Q1
$11.4M Buy
138,757
+6,409
+5% +$505K 1.15% 24
2021
Q4
$10.1M Buy
132,348
+5,308
+4% +$423K 0.93% 27
2021
Q3
$9.54M Buy
127,040
+6,797
+6% +$517K 0.86% 27
2021
Q2
$9.35M Buy
120,243
+5,939
+5% +$442K 0.8% 27
2021
Q1
$8.41M Buy
114,304
+11,105
+11% +$819K 0.78% 29
2020
Q4
$8.05M Buy
103,199
+5,886
+6% +$450K 0.8% 27
2020
Q3
$7.7M Buy
97,313
+7,316
+8% +$573K 0.86% 22
2020
Q2
$6.64M Buy
89,997
+4,588
+5% +$345K 0.92% 24
2020
Q1
$6.27M Buy
85,409
+22,425
+36% +$1.76M 1.09% 19
2019
Q4
$5.47M Buy
62,984
+5,451
+9% +$448K 1.02% 28
2019
Q3
$4.62M Buy
57,533
+5,469
+11% +$438K 0.96% 28
2019
Q2
$4.17M Buy
52,064
+9,366
+22% +$717K 0.88% 30
2019
Q1
$3.39M Buy
+42,698
New +$3.19M 0.71% 34

Other funds holding MRK

Brightworth's MRK Position: Q3 2022 in Review

Brightworth increased its Merck (MRK) stake by 0.28% in Q3 2022, buying an estimated $34.8K and bringing the position to 138,804 shares worth $12M. The position accounts for 1.28% of the portfolio, ranked #15.

Brightworth first reported a position in MRK in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.6M in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Brightworth held 138,804 shares of Merck worth $12M as of Q3 2022.
  • Brightworth bought 390 Merck shares in Q3 2022, an estimated $34.8K.
  • Merck made up 1.28% of Brightworth's portfolio in Q3 2022, its #15 holding.
  • Brightworth first reported a position in Merck in Q1 2019 and has held it in 15 quarters since.
  • Brightworth's Merck position peaked at $12.6M in Q2 2022.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Brightworth's 13F filing for Q3 2022, filed 28 Oct 2022.